Invasc Announces Financing and Board Changes
Date: Jul 09 2010
ATLANTA, Georgia – July 9, 2010 – InVasc Therapeutics, Inc. today has had a initial closing of $3,150,000 in its first institutional financing. The investment was led by Trois I Investments Industriels Internationaux S.A., headquartered in Luxembourg.
“We welcome Trois I and our other investors”, stated William Johnston, Ph.D., Chief Executive Officer of InVasc. “The funds raised will primarily be used to advance a Phase II trial for INV-144. The members of our new board will include Daniele Cardoso of Trois I, Larry Dillaha, the former EVP and Chief Medical Officer of Sciele Pharma, Bill Schaeffer, Chief Operating Officer of InVasc and me.” 
InVasc Therapeutics,Inc Awarded Two Phase 1 SBIR Grants
Date: May 19 2010
ATLANTA, Georgia – May 19, 2010 – InVasc Therapeutics, Inc. today announced that it has
been awarded two Small Business Innovations Research (SBIR) Phase 1 grants by the National
Institutes of Health. One grant is to continue research and development of small molecule
drugs for the prevention and treatment of hypertension and stroke based on derivatives of alpha
lipoic acid. The second grant is to advance the discovery and development of inhibitors of
myeloperoxidase for use in treating or preventing acute vascular or inflammatory events. The
aggregate funding from these two Phase 1 grants is nearly $400,000.
Georgia Governor Issues Commendation Recognizing
Date: Jan 19 2010
ATLANTA, Georgia – January 19, 2010 – InVasc Therapeutics, Inc. today announced that in
a ceremony held at the Georgia State Capital, Governor Sonny Perdue, presented a
Commendation to Dr. Bobby V. Khan, a cardiologist, founder and member of the Board of
Directors of InVasc. The Commendation states: “WHEREAS: Dr. Khan is a great asset for
our state and has worked tirelessly in his duties as a physician, researcher and educator. The
citizens of Georgia are thankful for his ongoing contributions to the health and betterment of
our state; now THEREFORE: I, Sonny Perdue, Governor of the state of Georgia, do hereby
commend Bobby V. Khan.”
InVasc Therapeutics to Present at Biotech Showcase 2010 and Announces Domain Name Change
Date: Jan 11 2010
ATLANTA, Georgia – January 11, 2010 – InVasc Therapeutics, Inc. today announced that
William D. Johnston, Ph.D., Chief Executive Officer, will present an overview of the Company
and its pipeline of products for the treatment and prevention of cardiometabolic diseases at the
Biotech Showcase 2010 meeting at the Marine Memorial Club and Hotel in San Francisco on
Wednesday January 14, 2010 at 4:40 P.M., Pacific Standard Time.